alzheimer-disease

Documents about alzheimer-disease

• Thalamic nuclei insights into Alzheimer's disease#314144bioRxiv / medRxiv
• Quantitation of Spatial Proteoforms in Alzheimer's Disease#422359bioRxiv / medRxiv
• Alzheimer's disease in patients prescribed statins: A real-world data analysis of U.S. patient health records#5615Europe PMC
• Baseline FDG-PET Brain hypometabolism as a predictive biomarker of cognitive decline and Alzheimer's disease risk#182055Europe PMC
• Comparative Analysis of Deep Learning Techniques in Alzheimer's Disease Diagnosis: Trends, Challenges, and Future Directions#205465Europe PMC
• Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease#212948Europe PMC
• The impact of the interaction between SIRT1 and lifestyle factors on Alzheimer’s disease risk and related phenotypes#223394Research Online
• Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimers disease in metabolically stressed APPswe/PS1dE9 mice#230965Dipòsit Digital de la Universitat de Barcelona
• Multimodal Machine Learning for Alzheimer's Disease Classification Using ADNI Biomarker Fusion#396647ODU Digital Commons
• Identification de facteurs de risque génétique liés au sexe pour la maladie d'Alzheimer#14158HAL (France)
• Situación actual de los indicadores de mortalidad por Alzheimer en Castilla y León#438757Gestión del Repositorio Documental de la Universidad de Salamanca
• Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results#184992Dipòsit Digital de la Universitat de Barcelona
• Repurposing FDA-approved drugs as multi-target neuroprotective agents for Alzheimer's disease via computational screening and experimental validation#5503Europe PMC
• Physical Exercise and Mechanism Related to Alzheimer’s Disease: Is Gut–Brain Axis Involved?#197444Repositorio UNAB
• Tracking of Neuroinflammation Dynamics During Combined Anti-β-Amyloid Therapy (AAT) and Immunomodulation in a Preclinical Alzheimer’s Disease Model#231289Europe PMC
• Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease#384127CiNii
• Functionally informed annotation influences pathway-specific polygenic risk and disease inference in Alzheimer's disease#307249bioRxiv / medRxiv
• Mapping individual molecular connectomes in Alzheimer's disease.#123051NCBI PubMed Central
• Brain Imaging in the Diabetes Prevention Program Outcomes Study#140952ClinicalTrials.gov
• Immune receptor LAG3 regulates microglia function during Alzheimer’s disease#217724Europe PMC
• Common biomarkers of Alzheimer disease and postoperative delirium.#250962NCBI PubMed Central
• Tau-Connectome Predictive Modeling and Subtyping in Preclinical Alzheimer's Disease#256630EliScholar
• Stress, stress systems, and Alzheimer's disease.#265469NCBI PubMed Central
• The Promise and Peril of Alzheimer Disease Prevention.#388642NCBI PubMed Central
• The Sleep Amyloid, Slow WAve Race and Ethnicity Study#411272ClinicalTrials.gov
• Exploring longitudinal relationships among Alzheimer's disease biomarkers.#420892NCBI PubMed Central
• Low Sensitivity of Neuropsychological Scales Hinder Detection of Potential Benefit of Treatments in Alzheimer's Disease: A Position Paper#5557Europe PMC
• Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study#8270HAL (France)
• Early metabolic changes in the brain of Alzheimer’s disease rats are driven by GLAST+ cells#274375HAL (France)
• Table 1_Dynamic changes of gut microbiota during progression of three Alzheimer’s disease mice models.xls#300637Figshare
• Identifying the determinants of hospital readmission in dementia patients – A retrospective cohort study using electronic healthcare records in England#372107PLOS
• AI-enabled in silico immunohistochemical characterization for Alzheimer's disease#492074eScholarship
• Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study#126052ClinicalTrials.gov
• Psychopathologie de la maladie d'Alzheimer : une approche clinique de la mémoire démentielle#235293HAL (France)
• Intersection Of Capacity Law And Neurodegenerative Disease With A Focus On Alzheimer’s Medication#401534EliScholar
• Cardiovascular Disease Subtypes and Alzheimer's Disease: Phenotypic and Genetic Associations in the UK Biobank and All of Us Research Program#383743Digital Commons @ Michigan Tech
• Los biomarcadores fónicos de la enfermedad de Alzheimer desde la perspectiva tipológica#475827Gestión del Repositorio Documental de la Universidad de Salamanca
• <i>Blautia coccoides</i>-derived metabolite trimethylamine-N-oxide exacerbates Alzheimer's disease progression via targeting HIF1α signaling#5183Europe PMC
• Predictive Genetic Testing for Alzheimer's Disease in Long-Term Care Insurance#167578Digital Commons @ University of Georgia School of Law
• The Role of Magnetic Resonance Spectroscopy (MRS), Diffusion-Tensor-Imaging (DTI) and Structural MRI in the Alzheimer's Disease and Mild Cognitive Impairment Diagnosis: A Review#253598Europe PMC
• Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer's Disease: Targeting mTOR and NGFR Pathways#320931SWU eJournals System
• From correlation to causation: cell‐type‐specific gene regulatory networks in Alzheimer's disease#609465eScholarship
• Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics#161197HAL (France)
• Studying the interaction between Polyoxometalates and Amyloid peptides in the context of Alzheimer’s disease#195713HAL (France)
• The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma.#3727NCBI PubMed Central
• Single-Nuclei Transcriptomic Characterization of APOE4-Associated Alzheimer's Disease#151551bioRxiv / medRxiv
• Imaging the Treatment of Alzheimer Disease: 2030 Could Look Very Different.#247506NCBI PubMed Central
• Hyperglycosylation is a metabolic driver of Alzheimer's disease.#317680NCBI PubMed Central
• Cross entropy gradient analysis for Alzheimer's disease assessment.#362112NCBI PubMed Central
• Effects of Hypoperfusion in Alzheimer's Disease#384150CiNii